Company statement of changes in equity

For the year ended 31 May 2016

Download (EXCEL)

 

 

  Share
capital
R’000
Share
premium
R’000
Treasury 
shares 
R’000 
Equity 
compensation 
benefit 
reserve 1
R’000 
Share-based
payment
reserve
R’000
Accumulated 
loss 
R’000 
Total 
equity 
R’000 
 
Balance as at 31 May 2014 4 012 359  (30 887) 12 246  295  (1 102 739) 2 891 274    
Net profit for the year  —  —  —  —  —  45 265  45 265    
Other comprehensive income  —  —  —  —  —  —  —    
Total comprehensive profit  —  —  —  —  —  45 265  45 265    
Shares purchased during the year  —  —  (19 131) —  —  —  (19 131)   
Shares awarded to Group companies as part of equity  —  —                   
compensation scheme  —  —  14 915  —  —  —  14 915    
Shares forfeited by Group companies as part of equity  —  —                   
compensation scheme  —  —  (3 346) —  —  —  (3 346)   
Equity compensation scheme shares vested  —  —  8 154  (8 154) —  —  —    
Equity compensation movements  —  —  —  11 274  —  —  11 274    
Dividends  —  —  —  —  —  (182 117) (182 117)   
Balance as at 31 May 2015  4 012 359  (30 295) 15 366  295  (1 239 591) 2 758 134    
Net profit for the year  —  —  —  —  —  180 046  180 046    
Other comprehensive income  —  —  —  —  —  —  —    
Total comprehensive profit  —  —  —  —  —  180 046  180 046    
Shares purchased during the year  —  —  (23 052) —  —  —  (23 052)   
Shares awarded to Group companies as part of equity  —  —                   
compensation scheme  —  —  16 989  —  —  —  16 989    
Shares forfeited by Group companies as part of equity  —  —                   
compensation scheme  —  —  (1 275) —  —  —  (1 275)   
Equity compensation scheme shares vested  —  —  8 648  (8 648) —  —  —    
Equity compensation movements  —  —  —  8 241  —  —  8 241    
Dividends  —  —  —  —  —  (209 098) (209 098)   
Balance as at 31 May 2016  4 012 359  (28 985) 14 959  295  (1 268 643) 2 729 985 
* Less than R1 000.
1 This relates to the Company’s movement in equity compensation benefit (refer to note 11).